Usefulness and limitations of serum and urine lysozyme levels in the classification of acute myeloid leukemia: An analysis of 208 cases

Leukemia Research

Volumn 20, Issue 6, 1996, Pages 467-472

  Sexton, Carol ^a   Buss, David H ^a   Powell, Bayard ^a   O'Connor, Michael ^a   Rainer, Robert ^a   Woodruff, Ralph ^a   Cruz, Julia ^a   Pettenati, Mark ^a   Rao, P Nagesh ^a   Case, L Douglas ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

FAB classification; Leukemia; Lysozyme

Indexed keywords

LYSOZYME;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; ENZYME BLOOD LEVEL; ENZYMURIA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030176369     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00001-X     Document Type: Article

References (12)

1. 1. Bennett J. M., Catovsky D., Daniel M.-T., Flandrin G., Galton D., Gralnick H. R. & Sultan C. (1976) Proposals for the classification of the acute leukaemias. Br. J. Haematol. 33, 451.
2. 2. Bennett J. M., Catovsky D., Daniel M.-T., Flandrin G., Galton D., Gralnick H. R. & Sultan C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Int. Med. 103, 626.
3. 3. Bennett J. M., Catovsky D., Daniel M.-T., Flandrin G., Galton D., Gralnick H. R. & Sultan C. (1985) Diagnosis of acute leukemia of megakaryocyte lineage (M7). Ann. Int. Med. 103, 460.
4. 4. Bennett J. M., Catovsky D., Daniel M.-T., Flandrin G., Galton D., Gralnick H. R. & Sultan C. (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML M0). Br. J. Haematol. 78, 325.
5. 5. Milligan D. W., Roberts B. E., Limbert H. J., Jalihal S. & Scott C. S. (1984) Cytochemical and immunological characteristics of acute monocytic leukaemia. Br. J. Haematol. 58, 391.
6. 6. Norfolk D. R., Davy M., Forbes M. A. & Scott C. S. (1985) Serum beta-2 microglobulin and lysozyme concentrations in 101 cases of untreated acute myeloid leukemia. Dis. Markers 3, 177.
7. 7. Scott C. S., Morgan M., Limbert H. J., MacKarill I. D. & Roberts B. E. (1985) Cytochemical, immunological, and ANAE-isoenzyme studies in acute myelomonocytic leukaemia: a study of 39 cases. Scand. J. Haematol. 35, 284.
8. 8. Furukawa Y., Ohta M., Miura Y. & Saito M. (1987) Interleukin-1 producing ability of leukaemia cells and its relationship to morphologic diagnosis. Br. J. Haematol. 65, 11.
9. 9. Öberg G., Dahl R., Ellegaard J., Sundstrom C., Vaeth C. & Venge P. (1987) Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme, and myeloperoxidase in acute myeloid leukemia: recognition of a new variant, high-lactoferrin AML. Eur. J. Haematol. 38, 148.
10. 10. Osserman E. R. & Lawlor D. P. (1966) Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Expl Med. 124, 921.
11. 11. Wiernik P. H. & Serpick A. A. (1969) Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am. J. Med. 46, 330.
12. 12. Krause J. R., Stoic V., Kaplan S. S. & Penchansky L. (1988) Microglandular promyelocytic leukemia: a multi-parameter approach. Am. J. Clin. Pathol. 90, 509 (abstr.).